A sea-change in rare disease drug development

23 February 2016

An overview of orphan drug development and considerations for how marketing strategies for these products need to change.

Find out more in the article by Caroline Mathie, Orphan Disease Specialist Research Group, and Dilip Phadnis, Head of Syndicated Studies at THE PLANNING SHOP.